FAM
GSK icon

Formidable Asset Management’s GSK GSK Stock Holding History

Formidable Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Sell
4,472
-16,837
-79% -$890K 0.04% 346
2026
Q1 		$1.04M Sell
21,309
-1,228
-5% -$66.5K 0.16% 129
2025
Q4 		$973K Buy
22,537
+12,306
+120% +$574K 0.14% 146
2025
Q3 		$393K Buy
10,231
+882
+9% +$34.5K 0.06% 284
2025
Q2 		$362K Hold
9,349
– – 0.06% 283
2025
Q1 		$362K Buy
9,349
+2,407
+35% +$88.1K 0.06% 283
2024
Q4 		$235K Buy
6,942
+1,490
+27% +$53.6K 0.04% 334
2024
Q3 		$223K Sell
5,452
-920
-14% -$37.6K 0.04% 336
2024
Q2 		$245K Sell
6,372
-170
-3% -$7.15K 0.04% 335
2024
Q1 		$280K Buy
6,542
+605
+10% +$24.9K 0.05% 288
2023
Q4 		$220K Buy
+5,937
New +$213K 0.05% 250
2016
Q2 		– Sell
-51
Closed -$2K – 270
2016
Q1 		$2K Hold
51
– – ﹤0.01% 458
2015
Q4 		$2K Hold
51
– – ﹤0.01% 514
2015
Q3 		$2K Buy
+51
New +$2.65K ﹤0.01% 570
2014
Q3 		– Sell
-51
Closed -$3K – 487
2014
Q2 		$3K Buy
+51
New +$3.45K ﹤0.01% 459
2014
Q1 		– Sell
-51
Closed -$3K – 474
2013
Q4 		$3K Buy
+51
New +$3.31K ﹤0.01% 448

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

Formidable Asset Management's GSK Position: Q2 2026 in Review

Formidable Asset Management reduced its GSK (GSK) stake by 79% in Q2 2026, selling an estimated $890K and leaving 4,472 shares worth $247K. The position accounts for 0.04% of the portfolio, ranked #346.

Formidable Asset Management first reported a position in GSK in Q4 2013 and has held it in 16 quarters since. The position peaked at $1.04M in Q1 2026. 196 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Formidable Asset Management held 4,472 shares of GSK worth $247K as of Q2 2026.
  • Formidable Asset Management sold 16,837 GSK shares in Q2 2026, an estimated $890K.
  • GSK made up 0.04% of Formidable Asset Management's portfolio in Q2 2026, its #346 holding.
  • Formidable Asset Management first reported a position in GSK in Q4 2013 and has held it in 16 quarters since.
  • Formidable Asset Management's GSK position peaked at $1.04M in Q1 2026.
  • 196 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.